Table 4 Number of compounds mapping into individual cellular response categories of SOM
From: Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening
| Â | F | J | M | N | P | Q | R | S | V |
|---|---|---|---|---|---|---|---|---|---|
(a) | 29 (4.2%) | 44 (6.4%) | 129 (18.7%) | 102 (14.8%) | 92 (13.3%) | 83 (12.0%) | 25 (3.6%) | 140 (20.3%) | 46 (6.7%) |
(b) | 5 (2.6%) | 7 (3.6%) | 70 (36.1%) | 16 (8.2%) | 25 (12.9%) | 13 (6.7%) | 5 (2.6%) | 42 (21.6%) | 11 (5.7%) |
(c) | 3 (1.9%) | 5 (3.1%) | 62 (38.5%) | 16 (9.9%) | 19 (11.8%) | 9 (5.6%) | 3 (1.9%) | 35 (21.7%) | 9 (5.6%) |
(d) | 2 (7.4%) | 1 (3.7%) | 6 (22.2%) | 0 (0%) | 5 (18.5%) | 4 (14.8%) | 1 (3.7%) | 7 (25.9%) | 1 (3.7%) |
p-ab | 0.3988 | 0.1653 | <0.0001 | 0.0169 | 1.0000 | 0.0365 | 0.6537 | 0.6882 | 0.7412 |
p-ac | 0.2469 | 0.1326 | <0.0001 | 0.1283 | 0.6970 | 0.0163 | 0.3325 | 0.6663 | 0.7235 |
p-ad | Numbers too small for statistical evaluation | ||||||||